Arvid Carlsson
Arvid Carlsson (25 January 1923 – 29 June 2018) was a Swedish neuropharmacologist. He was best known for his work with the neurotransmitter dopamine and its effects on Parkinson's disease.
Arvid Carlsson | |
|---|---|
 | |
| Born | 25 January 1923 Uppsala, Sweden |
| Died | 29 June 2018 (aged 95) Gothenburg, Sweden |
| Nationality | Swedish |
| Alma mater | Lund University |
| Known for | Dopamine |
| Awards | Nobel Prize in Physiology or Medicine (2000) |
He won the Wolf Prize in Medicine in 1979.
For his work on dopamine, Carlsson was awarded the Nobel Prize in Physiology or Medicine in 2000.[1] He won the award alongside Eric Kandel and Paul Greengard.
References
- Barondes, Samuel H. (2003). Better Than Prozac. New York: Oxford University Press. pp. 21–22, 39–40. ISBN 0-19-515130-5.
Other websites
Authority control  | |
|---|---|
| General | |
| National libraries | |
| Scientific databases | |
| Other | |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.